Insmed Inc INSM

NAS: INSM | ISIN: US4576693075 20/03/2026

136,00 USD (-5,56%)

(-5,56%) 20/03/2026

Grafiek Insmed Inc

Grafiek Insmed Inc

1 dag1d -5,56%
1 week1w -5,95%
1 maand1m -14,48%
3 maanden3m -22,62%
6 maanden6m -6,23%
1 jaar1j 71,33%
5 jaar5j 261,80%

Insmed Inc in het nieuws

Toon enkel gratis nieuws

5 maart 2026 · Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

19 februari 2026 · Insmed Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides Business Update · Persbericht

13 februari 2026 · Insmed To Present at March 2026 Investor Conferences · Persbericht

5 februari 2026 · Insmed to Host Fourth-Quarter and Full-Year 2025 Financial Results Conference Call on Thursday, February 19, 2026 · Persbericht

28 januari 2026 · Insmed to Present Multiple Abstracts on Treprostinil Palmitil Inhalation Powder (TPIP) at Pulmonary Vascular Research Institute (PVRI) 2026 Congress · Persbericht

9 januari 2026 · Insmed Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference · Persbericht

2 januari 2026 · Insmed To Present at the 44th Annual J.P. Morgan Healthcare Conference · Persbericht

17 december 2025 · Insmed Provides Clinical and Business Update · Persbericht

4 december 2025 · Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

18 november 2025 · European Commission Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union · Persbericht

Profiel Insmed Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.insmed.com

Hoofdzetel: Bridgewater, New Jersey Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe